Eiger BioPharmaceuticals, Inc. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Option Exercise | M | 8.00 | 4,000 | 32,000 | 175,738 | |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Option Exercise | M | 1.12 | 10,000 | 11,200 | 179,738 | |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Sell | S | 16.08 | 4,000 | 64,320 | 2,895 | 6.9 K to 2.9 K (-58.01 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Sell | S | 16.08 | 10,000 | 160,800 | 6,895 | 16.9 K to 6.9 K (-59.19 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Buy | M | 8.00 | 4,000 | 32,000 | 16,895 | 12.9 K to 16.9 K (+31.02 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Buy | M | 1.12 | 10,000 | 11,200 | 12,895 | 2.9 K to 12.9 K (+345.42 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Option Exercise | M | 8.00 | 6,629 | 53,032 | 741,579 | |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Option Exercise | M | 1.12 | 41,302 | 46,258 | 748,208 | |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Sell | S | 15.94 | 6,629 | 105,666 | 3,125 | 9.8 K to 3.1 K (-67.96 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Sell | S | 15.85 | 41,302 | 654,637 | 9,754 | 51.1 K to 9.8 K (-80.90 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Buy | M | 8.00 | 6,629 | 53,032 | 51,056 | 44.4 K to 51.1 K (+14.92 %) |
| Feb 10 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Buy | M | 1.12 | 41,302 | 46,258 | 44,427 | 3.1 K to 44.4 K (+1,321.66 %) |
| Feb 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Option Exercise | M | 1.12 | 7,777 | 8,710 | 151,795 | |
| Feb 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Sell | S | 16.35 | 7,777 | 127,154 | 1,432 | 9.2 K to 1.4 K (-84.45 %) |
| Feb 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Buy | M | 1.12 | 7,777 | 8,710 | 9,209 | 1.4 K to 9.2 K (+543.09 %) |